BUY Choice International Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))9 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Choice International Ltd's material subsidiary, Choice Equity Broking Private Limited, is issuing Compulsory Convertible Preference Shares (CCPS) to NH Investment & Securities Co. Ltd.
BSE · Company Update·9 Jul · 1w ago
Choice International Ltd's material subsidiary, Choice Equity Broking Private Limited, executed definitive agreements for strategic investment via CCPS issuance to NH Investment & Securities Co. Ltd.
BSE · Company Update·9 Jul · 1w ago
Choice International Ltd's material subsidiary, Choice Equity Broking Pvt. Ltd., executed definitive agreements for strategic investment via CCPS issuance to NH Investment & Securities Co. Ltd.
BSE · Company Update·9 Jul · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Choice International
- BUY — IDBI Capital20 Aug 2026 · ~2 weeks · target ₹878 · SL hit
- BUY — Ansh Jogendra Bhilwar11 Aug 2026 · ~2 weeks · target ₹930 · SL hit
- BUY — Rupak De, LKP Securities5 Aug 2026 · ~2 weeks · target ₹880 · Expired
- BUY — Sahi Research31 Jul 2026 · ~2 weeks · target ₹840 · Target hit
- BUY — Ashish Kyal, Waves Strategy Advisors3 Jun 2026 · ~2 weeks · target ₹720 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

